Effect of dietary status on plasma-fractionated metanephrines in healthy individuals measured by Elisa

References

• Lenders, J. W.; Duh, Q. Y.; Eisenhofer, G.;Gimenez-Roqueplo, A. P.; Grebe, S. K.; Murad, M. H.; Naruse, M.; Pacak, K.; Ypung, W. F., Jr. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2014, 99, 1915–1942. DOI: 10.1210/jc.2014-1498.
   PubMed Web of Science ®Google Scholar
• Jain, A.; Baracco, R.; Kapur, G. Pheochromocytoma and Paraganglioma-An Update on Diagnosis, Evaluation, and Management. Pediatr. Nephrol. 2019. DOI: 10.1007/s00467-018-4181-2.
   PubMed Web of Science ®Google Scholar
• Mula-Abed, W. A.; Ahmed, R.; Ramadhan, F. A.; Al-Kindi, M. K.; Al-Busaidi, N. B.; Al-Muslahi, H. N.; Al-Lamki, M. A. A Rare Case of Adrenal Pheochromocytoma with Unusual Clinical and Biochemical Presentation: A Case Report and Literature Review. Oman Med. Journal. 2015, 30, 382–390.
   PubMedGoogle Scholar
• Hickman, P. E.; Leong, M.; Chang, J.; Wilson, S. R.; McWhinney, B. Plasma Free Metanephrines are Superior to Urine and Plasma Catecholamines and Urine Catecholamine Metabolites for the Investigation of Phaeochromocytoma. Pathology. 2009, 41, 173–177.
   PubMed Web of Science ®Google Scholar
• van Berkel, A.; Lenders, J. W.; Timmers, H. J. Diagnosis of Endocrine Disease: Biochemical Diagnosis of Phaeochromocytoma and Paraganglioma. Eur. J. Endocrinol. 2014, 170, R109–19.
   PubMed Web of Science ®Google Scholar
• de Jong, W. H.; de Vries, E. G.; Kema, I. P. Current Status and Future Developments of LC-MS/MS in Clinical Chemistry for Quantification of Biogenic Amines. Clin. Biochem. 2011, 44, 95–103.
   PubMed Web of Science ®Google Scholar
• Zheng, J.; Mandal, R.; Wishart, D. S. A Sensitive, High-Throughput LC-MS/MS Method for Measuring Catecholamines in Low Volume Serum. Anal. Chim. Acta. 2018, 1037, 159–167.
   PubMed Web of Science ®Google Scholar
• Heideloff, C.; Payton, D.; Wang, S. Quantitation of Free Metanephrines in Plasma by Liquid Chromatography-Tandem Mass Spectrometry. Methods Mol. Biol. 2016, 1378, 139–147.
   PubMedGoogle Scholar
• Peaston, R. T.; Weinkove, C. Measurement of Catecholamines and Their Metabolites. Ann. Clin. Biochem. 2004, 41, 17–38.
   PubMed Web of Science ®Google Scholar
• Peitzsch, M.; Prejbisz, A.; Kroiss, M.; Beuschlein, F.; Arlt, W.; Januszewicz, A.; Siegert, G.; Eisenhofer, G. Analysis of Plasma 3-Methoxytyramine, Normetanephrine and Metanephrine by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry: Utility for Diagnosis of Dopamine-Producing Metastatic Phaeochromocytoma. Ann. Clin. Biochem. 2013, 50, 147–155. DOI: 10.1258/acb.2012.012112.
   PubMed Web of Science ®Google Scholar
• Nieć, D.; Kunicki, P. K. Validation of an Assay for Quantification of Free Normetanephrine, Metanephrine and Methoxytyramine in Plasma by High-Performance Liquid Chromatography with Coulometric Detection: Comparison of Peak-Area Vs. Peak-Height Measurements. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2015, 1002, 63–70. DOI: 10.1016/j.jchromb.2015.07.004.
   PubMed Web of Science ®Google Scholar
• Weismann, D.; Peitzsch, M.; Raida, A.; Prejbisz, A.; Gosk, M.; Riester, A.; Willenberg, H. S.; Klemm, R.; Manz, G.; Deutschbein, T.; et al. Measurements of Plasma Metanephrines by Immunoassay Vs Liquid Chromatography with Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma. Eur. J. Endocrinol. 2015, 172, 251–260. DOI: 10.1530/EJE-14-0730.
   PubMed Web of Science ®Google Scholar
• Sarathi, V.; Pandit, R.; Jagtap, V.; Lila, A. R.; Bandgar, T. R.; Menon, P. S.; Varthakavi, P.; Raghavan, V. P.; Shah, N. S. Performance of Plasma Fractionated Free Metanephrines by Enzyme Immunoassay in the Diagnosis of Pheochromocytoma and Paraganglioma. Endocr. Pract. Off. J. Am. Coll. Endocrinol. Am. Assoc. Clin. Endocrinologists. 2011, 17, 759–765. DOI: 10.4158/EP11058.OR.
   Google Scholar
• Pacak, K.; Linehan, W. M.; Eisenhofer, G.; Walther, M. M.; Goldstein, D. S. Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma. Ann. Internal Med. 2001, 134, 315–329.
   PubMed Web of Science ®Google Scholar
• Christensen, T. T.; Frystyk, J.; Poulsen, P. L. Comparison of Plasma Metanephrines Measured by a Commercial Immunoassay and Urinary Catecholamines in the Diagnosis of Pheochromocytoma. Scand. J. Clin. Lab. Invest. 2011, 71, 695–700. DOI: 10.3109/00365513.2011.622410.
   PubMed Web of Science ®Google Scholar
• Gao, Y.-C.; Lu, H.-K.; Luo, Q.-Y.; Chen, L.-B.; Ding, Y.; Zhu, R.-S., Gao YC, Lu HK, Luo QY, Chen LB, Ding Y, Zhu RS. Comparison of Free Plasma Metanephrines Enzyme Immunoassay with (131)I-MIBG Scan in Diagnosis of Pheochromocytoma. Clin. Exp. Med. 2008, 8, 87–91. DOI: 10.1007/s10238-008-0162-2.
   PubMed Web of Science ®Google Scholar
• Procopiou, M.; Finney, H.; Akker, S. A.; Chew, S. L.; Drake, W. M.; Burrin, J.; Grossman, A. B. Evaluation of an Enzyme Immunoassay for Plasma-Free Metanephrines in the Diagnosis of Catecholamine-Secreting Tumors. Eur. J. Endocrinol. 2009, 161, 131–140. DOI: 10.1530/EJE-09-0172.
   PubMed Web of Science ®Google Scholar
• Gunn-Christie, R. G.; Flatland, B.; Friedrichs, K. R.; Szladovits, B.; Harr, K. E.; Ruotsalo, K.; Knoll, J. S.; Wamsley, H. L.; Freeman, K. P. ASVCP Quality Assurance Guidelines: Control of Preanalytical, Analytical, and Postanalytical Factors for Urinalysis, Cytology, and Clinical Chemistry in Veterinary Laboratories. Vet. Clin. Pathol. 2012, 41, 18–26. DOI: 10.1111/j.1939-165X.2012.00412.x.
   PubMed Web of Science ®Google Scholar
• Schovanek, J.; Martucci, V.; Wesley, R.; Fojo, T.; Del Rivero, J.; Huynh, T.; Adams, K.; Kebebew, E.; Frysak, Z.; Stratakis, C. A.; et al. The Size of the Primary Tumor and Age at Initial Diagnosis are Independent Predictors of the Metastatic Behavior and Survival of Patients with SDHB-related Pheochromocytoma and Paraganglioma: A Retrospective Cohort Study. BMC Cancer. 2014, 14, 523. DOI: 10.1186/1471-2407-14-523.
   PubMed Web of Science ®Google Scholar
• Corcuff, J. B.; Chardon, L.; El Hajji Ridah, I.; Brossaud, J. Urinary Sampling for 5HIAA and Metanephrines Determination: Revisiting the Recommendations. Endocr. Connections. 2017, 6, R87–R98.
   PubMed Web of Science ®Google Scholar
• Casey, R.; Griffin, T. P.; Wall, D.; Dennedy, M. C.; Bell, M.; O’Shea, P. M. Screening for Phaeochromocytoma and Paraganglioma: Impact of Using Supine Reference Intervals for Plasma Metanephrines with Samples Collected from Fasted/Seated Patients. Ann. Clin. Biochem. 2017, 54, 170–173.
   PubMed Web of Science ®Google Scholar
• Abraham, S. C., . R.; Pitfield, D.; Challis, B.; Simpson, H. A Review of the Diagnostic Sensitivity of Plasma Metanephrine Testing in Patients with SDH Gene Mutations. Endocrine Abstr. 2016, 44, 127.
   Google Scholar
• Plasma Free Metadrenalines (Metanephrines), 2018. Available at: https://labtestsonline.org.uk/tests/plasma-free-metadrenalines-metanephrines
   Google Scholar
• Willemsen, J. J.; Sweep, C. G.; Lenders, J. W.; Ross, H. A. Stability of Plasma Free Metanephrines during Collection and Storage as Assessed by an Optimized HPLC Method with Electrochemical Detection. Clin. Chem. 2003, 49, 1951–1953.
   PubMed Web of Science ®Google Scholar
• Darr, R.; Pamporaki, C.; Peitzsch, M.; Miehle, K.; Prejbisz, A.; Peczkowska, M.; Weismann, D.; Beuschlein, F.; Sinnott, R.; Bornstein, S. R.; et al. Biochemical Diagnosis of Phaeochromocytoma Using Plasma-Free Normetanephrine, Metanephrine and Methoxytyramine: Importance of Supine Sampling under Fasting Conditions. Clin. Endocrinol. 2014, 80, 478–486.
   PubMed Web of Science ®Google Scholar
• Eisenhofer, G.; Lattke, P.; Herberg, M.; Siegert, G.; Qin,  N.; Darr, R.; Hoyer, J.; Villringer, A.; Prejbisz, A.; Januszewicz, A.; et al. Reference Intervals for Plasma Free Metanephrines with an Age Adjustment for Normetanephrine for Optimized Laboratory Testing of Phaeochromocytoma. Ann. Clin. Biochem. 2013, 50, 62–69.
   PubMed Web of Science ®Google Scholar
• Lenders, J. W.; Pacak K; Walther, M. M.; Linehan, W. M.; Mannelli, M.; Friberg, P.; Keiser, H. R.; Goldstein, D. S.; Eisenhofer, G. Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best?. Jama. 2002, 287, 1427–1434.
   PubMed Web of Science ®Google Scholar
• Young, W. F., Jr.;. Pheochromocytoma and Primary Aldosteronism: Diagnostic Approaches. Endocrinol. Metab. Clinics North Am. 1997, 26, 801–827.
   PubMed Web of Science ®Google Scholar
• Eisenhofer, G. P., . M.; McWhinney, B. C. Impact of LC-MS/MS on the Laboratory Diagnosis of Catecholamine-Producing Tumors. Trends Anal. Chem. 2016, 84, 106–116.
   Web of Science ®Google Scholar
• Lee, G. R.; Johnston, P. C.; Atkinson, A. B.; McKillop, D.; Auld, P.; Hunter, S. J. A Comparison of Plasma-Free Metanephrines with Plasma Catecholamines in the Investigation of Suspected Pheochromocytoma. J. Hypertens. 2011, 29, 2422–2428.
   PubMed Web of Science ®Google Scholar
• Eisenhofer, G.; Keiser, H.; Friberg, P.; Mezey, E.; Huynh, T. T.; Hiremagalur, B.; Ellingson, T.; Duddempudi, S.; Eijsbouts, A.; Lenders, J. W. Plasma Metanephrines are Markers of Pheochromocytoma Produced by catechol-O-methyltransferase within Tumors. J. Clin. Endocrinol. Metab. 1998, 83, 2175–2185.
   PubMed Web of Science ®Google Scholar
• Eisenhofer, G.; Walther, M.; Keiser, H. R.; Lenders, J. W.; Friberg, P.; Pacak, K. Plasma Metanephrines: A Novel and Cost-Effective Test for Pheochromocytoma. Braz. J. Med. Biol. Res. Revista Brasileira De Pesquisas Medicas E Biologicas. 2000, 33, 1157–1169.
   PubMed Web of Science ®Google Scholar
• Eldrup, E.; Moller, S. E.; Andreasen, J.; Christensen, N. J. Effects of Ordinary Meals on Plasma Concentrations of 3,4-Dihydroxyphenylalanine, Dopamine Sulphate and 3,4-Dihydroxyphenylacetic Acid. Clinical Sci. 1997, 92, 423–430.
   PubMed Web of Science ®Google Scholar
• Goldstein, D. S.; Swoboda, K. J.; Miles, J. M.; Coppack, S. W.; Aneman, A.; Holmes, C.; Lamensdorf, I.; Eisenhofer, G. Sources and Physiological Significance of Plasma Dopamine Sulfate. J. Clin. Endocrinol. Metab. 1999, 84, 2523–2531.
   PubMed Web of Science ®Google Scholar
• de Jong, W. H.; Eisenhofer, G.; Post, W. J.; Muskiet, F. A.; de Vries, E. G.; Kema, I. P. Dietary Influences on Plasma and Urinary Metanephrines: Implications for Diagnosis of Catecholamine-Producing Tumors. J. Clin. Endocrinol. Metab. 2009, 94, 2841–2849.
   PubMed Web of Science ®Google Scholar
• Caini, F. W.; Zhao, H. Evaluation of an Enzyme Immunoassay for Plasma-Free Metanephrines in the Localization and Qualitative Diagnosis of Pheochromocytoma and Paraganglioma. J. Hypertens. 2018, 36, e134.
   Web of Science ®Google Scholar
• Darr, R.; Kuhn, M.; Bode, C.; Bornstein, S. R.; Pacak, K.; Lenders, J. W. M.; Eisenhofer, G. Accuracy of Recommended Sampling and Assay Methods for the Determination of Plasma-Free and Urinary Fractionated Metanephrines in the Diagnosis of Pheochromocytoma and Paraganglioma: A Systematic Review. Endocrine. 2017, 56, 495–503.
   PubMed Web of Science ®Google Scholar
• de Jong, W. H.; Post, W. J.; Kerstens, M. N.; de Vries, E. G.; Kema, I. P. Elevated Urinary Free and Deconjugated Catecholamines after Consumption of a Catecholamine-Rich Diet. J. Clin. Endocrinol. Metab. 2010, 95, 2851–2855.
   PubMed Web of Science ®Google Scholar
• Deutschbein, T.; Unger, N.; Jaeger, A.; Broecker-Preuss, M.; Mann, K.; Petersenn, S. Influence of Various Confounding Variables and Storage Conditions on Metanephrine and Normetanephrine Levels in Plasma. Clin. Endocrinol. 2010, 73, 153–160.
   PubMed Web of Science ®Google Scholar
• Kim, H. J.; Lee, J. I.; Cho, Y. Y.; Lee, S. Y.; Kim, J. H.; Jung, B. C.; Kim, S. W.; Chung, J. H.; Min, Y. K.; Lee, M. S.; Lee, M. K.; et al. Diagnostic Accuracy of Plasma Free Metanephrines in a Seated Position Compared with 24-Hour Urinary Metanephrines in the Investigation of Pheochromocytoma. Endocr. J. 2015, 62, 243–250.
   PubMed Web of Science ®Google Scholar
• Goldstein, D. S.; Eisenhofer, G.; Kopin, I. J. Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans. J. Pharmacol. Exp. Ther. 2003, 305, 800–811.
   PubMed Web of Science ®Google Scholar